• SPX
  • 5969.34
  • 0.35 %
  • 20.6299
  • DJI
  • 44296.51
  • 0.97 %
  • 426.1602
  • N225
  • 38283.85
  • 0.68 %
  • 257.6797
  • FTSE
  • 8262.08
  • 1.38 %
  • 112.8101
  • IXIC
  • 19003.65
  • 0.16 %
  • 31.2305
DexCom, Inc. (DXCM) Stock Price, News & Analysis

DexCom, Inc. (DXCM) Stock Price, News & Analysis

Currency in USD Disclaimer

$72.82

-$1.64

(-2.2%)

Day's range
$72.52
Day's range
$75.29
50-day range
$64.76
Day's range
$78.16
  • Country: US
  • ISIN: US2521311074
52 wk range
$62.34
Day's range
$142


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 5.80
  • Piotroski Score 5.00
  • Grade Outperform
  • Symbol (DXCM)
  • Company DexCom, Inc.
  • Price $72.82
  • Changes Percentage (-2.2%)
  • Change -$1.64
  • Day Low $72.52
  • Day High $75.29
  • Year High $142.00

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 02/06/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $95.00
  • High Stock Price Target $146.00
  • Low Stock Price Target $28.13
  • Potential Upside/Downside N/A
  • Consensus Rating Neutral
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $1.55
  • Trailing P/E Ratio 74.7
  • Forward P/E Ratio 74.7
  • P/E Growth 74.7
  • Net Income $541.50 M

Income Statement

Quarterly

Annual

Latest News of DXCM

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

DexCom, Inc. Frequently Asked Questions

  • What were the earnings of DXCM in the last quarter?

    In the last quarter DexCom, Inc. earnings were on Thursday, October, 24th. The DexCom, Inc. maker reported $0.45 EPS for the quarter, beating analysts' consensus estimates of $0.43 by $0.02.

  • What is the DexCom, Inc. stock price today?

    Today's price of DexCom, Inc. is $72.82 — it has decreased by -2.2% in the past 24 hours. Watch DexCom, Inc. stock price performance more closely on the chart.

  • Does DexCom, Inc. release reports?

    Yes, you can track DexCom, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the DexCom, Inc. stock forecast?

    Watch the DexCom, Inc. chart and read a more detailed DexCom, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is DexCom, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by DexCom, Inc. stock ticker.

  • How to buy DexCom, Inc. stocks?

    Like other stocks, DXCM shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is DexCom, Inc.'s EBITDA?

    DexCom, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in DexCom, Inc.’s financial statements.

  • What is the DexCom, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is 0.1494906551, which equates to approximately 14.95%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in DexCom, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including DexCom, Inc.'s financials relevant news, and technical analysis. DexCom, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for DexCom, Inc. stock currently indicates a “sell” signal. For more insights, review DexCom, Inc.’s technical analysis.

  • A revenue figure for DexCom, Inc. for its last quarter?

    DexCom, Inc. published it's last quarterly revenues at $994.20 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.